i2I HEADLINES

The i2I Final Pitch is where scientists and engineers display their entrepreneurial mindset, the necessary trait to commercialize their innovation. Six Finalists selected from the most recent i2I Skills Training cohort prepare a five-minute pitch and then face sharp, insightful questions from a panel of industry and academic judges. What does it look like when […]

“The i2I Program transformed my journey from a surgeon with an idea into the founder of Rise Medical Innovations, equipped with a clear business strategy and the confidence to speak the language of entrepreneurship,” said competition winner Dr. Shubha De. “Balancing life as a parent, PhD student and full-time clinician, I found the program’s mentorship,

“For myself, the i2I Program has allowed me to quickly yet efficiently, with the support of highly qualified instructors and mentors, navigate the ins and outs of the business world … The i2I Program has broadened my horizons and perspective to think about the purpose of my work beyond the confines of the laboratory.” —

LINK TO GOVERNMENT OF CANADA RELEASE The Ministry of Innovation, Science and Economic Development announced funding to establish the National Invention to Innovation (i2I) Network, expanding the award-winning Invention to Innovation program founded at Simon Fraser University (SFU) in 2015. The groundbreaking program provides innovation, commercialization and entrepreneurship training for students, researchers and highly qualified personnel in STEM

Link to Article October 28, 2024 Liz Mahon and BryoSphere Biotechnologies won first place and $5,000 at this year’s Invention to Innovation (i2I) Pitch Competition for their work turning moss into sustainable biofactories to make bioactive ingredients for skincare. The annual event at SFU’s Beedie School of Business celebrates entrepreneurial scientists who have completed the Invention

https://researchmoneyinc.com/article/creating-commercialization-postdocs-bridging-the-gap-between-invention-and-commercial-application August 7, 2024 Elicia Maine is Associate Vice-President, Knowledge Mobilization and Innovation, Simon Fraser University, and W.J. VanDusen Professor of Innovation & Entrepreneurship in the Beedie School of Business at SFU. Science-based innovations – those founded on engineering, scientific and medical discoveries – are critical to tackling global challenges. Canada’s brightest minds are generating

https://sciencepolicy.ca/posts/transformational-innovation-begins-with-universities/ As climate change intensifies, so does the urgency to reduce greenhouse gas emissions and bring clean energy options to the market. The demand for hydrogen energy is on the rise as countries seek to decarbonize. According to the International Renewable Energy Agency[1], by 2050, the hydrogen economy is projected to represent trillions of dollars

https://beedie.sfu.ca/ideas/2023/10/nanorobots-and-hydrogen-fuel-cell-technology-among-i2i-venture-pitch-2023-winners/ Advancements in mRNA drug delivery with nanorobots and hydrogen fuel cell technology took home the prizes at this year’s invention to Innovation (i2I) Venture Competition at SFU’s Beedie School of Business. The annual event is a platform celebrating a group of entrepreneurial scientists graduating from SFU Beedie’s Invention to Innovation (i2I) Graduate Certificate in Science and Technology

News from this article https://sciencepolicy.ca/programs/awards/award-winners/trailblazer-award-winners/ Dr. Elicia Maine, Associate Vice-President, Knowledge Mobilization and Innovation at Simon Fraser University, was selected for her work on the i2I program, which was tailor-made to mobilize university research, teach science and technology commercialization, and develop an entrepreneurial mindset in graduate scientists and engineers. Dr. Maine recognized key gaps in

  https://beedie.sfu.ca/ideas/2022/07/sfu-beedie-founded-invention-to-innovation-i2i-program-developing-scientist-innovators-for-major-international-collaboration-on-spinal-cord-research/     Oscar Seira, Mitacs Invention to Innovation (i2I) finalist in 2022. Seira presented the initial commercialization strategy for an injectable and functionalized biomaterial for spinal cord injury repair.   The quest to repair severed spinal cords has brought together the brightest minds from across institutions and disciplines in a spinal cord injury